TrialCancer medicine2018

Five-year results of a phase II trial of preoperative 5-fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2-positive patients) for patients with stage II or III breast cancer.

Frankie Ann Holmes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.